"The Doctor does not treat mankind except accidentally...So if someone...
knows the universal without knowing the individuals contained in it, he will often fail in his
treatment; for it is the individual that has to be treated."

Aristotle, Metaphysics

What is this event about?

About the conference Following the successes of our previous events on pharmacogenomics, biomarkers and stem cells, SMi is proud to present its inaugural conference on Personalised Medicine. Taking place in London, UK, this conference will look at the latest in science, R&D, business strategies and legal issues for developing personalised therapeutics, and successfully introducing them to the marketplace. Covering various approaches towards developing personalised therapeutics - biomarkers, pharmacogenomics, pharmacogenetics and stem cells, the conference will introduce both a pharmaceutical industry and a diagnostics industry perspective on the best way to move forward with developing companion diagnostics, marketing strategies, reimbursement issues and making personalised medicine viable in a commercial marketplace. Issues considered during the conference will include: Should pharma develop companion diagnostics internally, partner, or acquire diagnostic technologies? Is co-development the best method for companion diagnostics? What is the regulatory perspective on stratified and personalised therapeutics? How can the industry be creative with partnering strategies? Can current blockbuster drugs be repositioned as personalised medicines through resequencing? How do we identify and validate biomarkers for personalised medicines? Are pharmacogenomics and pharmacogenetics the right way forward? How far can stem cell technologies be used to personalise therapeutics? Why not attend the associated workshop as well? Associated with the conference there will be a half-day interactive workshop on "What's Holding Personalised Medicine Back - How Can We Move It Forward?", taking place on 13th October.  It will cover biomarker validation and qualification, clinical trial design and analysis for personalised therapeutics and intellectual property, ethical and policy issues.  This will be led by Shawnmarie Mayrand-Chung from the Biomarkers Consortium at the US National Institutes of Health.  To see more information about the workshop, please see the Personalised Medicine workshop page. Keen to see the detailed programme?  Click here. Want to download the brochure?  Click here. Register for the event here! Group discounts available - click here   Fancy speaking at the conference?  Do you know of anyone who may be interested in speaking?  We are always on the look-out for new speakers for our upcoming conferences.  Let us know: contact the Conference Producer. For sponsorship and exhibitioning opportunities, contact our Sponsorship Department.

Why should you attend this event?

Why should you attend this event?

What you will learn about The state of the market: the pharma and diagnostics perspective on how to develop and market personalised medicines and their companion diagnostics Research and development: the latest developments in R&D Pharmacogenomics: using pharmacogenomics and pharmacogenetics to develop personalised therapeutics Biomarkers: Identifying, developing and validating biomarkers as tools for personalised medicine Stem cells: Using stem cell technology to implement a more personalised therapeutic regime

How you will benefit Hear from some of the leading experts in the science and business development of personalised medicines Learn the differing views and strategies of pharma and diagnostics Discover the best ways to manage partnerships and develop companion diagnostics Network with the experts you need to know in the personalised medicine arena

Hear keynote addresses from:

Who is chairing this event?

Who is speaking at this event?

Who should attend?

Who should attend this event?

Chief Executives, Vice Presidents, Heads, Directors, Chief Scientists and Project Leaders of Personalised Medicine / Therapeutics Pharmacogenomics Pharmacogenetics Molecular Diagnostics Companion Diagnostic Development Strategic Partnering Business Development Worldwide Commercial Development Translational Sciences/Medicine Experimental Medicine Biomarkers Marketing

Delegates at our previous biomarkers and stem cells conferences came from across the world

Venue details

Where is the event being held?

Crowne Plaza London - The City The Crowne Plaza London - The City is a modern and stylish central London hotel in the heart of the City of London.  This deluxe hotel is just a step from Blackfriars Mainline Train Station which has a direct connection to St. Pancras International Eurostar Terminal. The hotel is a short walk from either Temple or Mansion House tube stations on the District & Circle lines or from St Paul's tube station on the Central Line.  Blackfriars tube station is currently closed due to the extensive renovation works taking place as part of the new Crossrail project. Crowne Plaza London - The City is ideally located for business and leisure, minutes away from some of London's most famous attractions: The London Eye, St Paul's Cathedral, the Millennium Bridge, Tate Modern and West End theatres. Crowne Plaza Club rooms, King Studios and Suites are available at your request. High Speed Internet access is offered in all fully air-conditioned bedrooms. Indulge at one of the hotel's three restaurants or bar.  Our acclaimed award winning Refettorio restaurant, directed by Michelin starred Chef Giorgio Locatelli, is the place to be seen in the city.  A sensational Asian alternative is the newly opened Chinese Cricket Club.  For those seeking fitness and relaxation, our Fitness Club with sauna is complimentary to all hotel guests.

19 New Bridge Street  EC4V 6DB

Tel: +44 (0) 870 4009 190    Fax: +44 (0) 207 4388 080

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.

Conference Documentation

Transcription CD ROM